CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models (Q42704187)
Jump to navigation
Jump to search
scientific article published on July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models |
scientific article published on July 2014 |
Statements
1 reference
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models (English)
1 reference
Agnieszka K Witkiewicz
1 reference
Derek Cox
1 reference
Erik S Knudsen
1 reference